Chemed Reports Fourth-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Chemed (CHE) PT Raised to $275 at Oppenheimer Following 4Q Beat
February 15, 2018 10:17 AM ESTOppenheimer raised its price target on Chemed (NYSE: CHE) to $275.00 (from $270.00) while maintaining a Outperform rating following the company's 4Q earnings report. CHE reported adjusted EPS of $2.32 vs. the Street's $2.27.
Following the quarter, Chemed issued impressive FY2018 EPS guidance of $10.60-$10.85, well... More
Chemed Corporation (CHE) Tops Q4 EPS by 5c
February 14, 2018 4:24 PM ESTChemed Corporation (NYSE: CHE) reported Q4 EPS of $2.32, $0.05 better than the analyst estimate of $2.27. Revenue for the quarter came in at $428 million versus the consensus estimate of $423.83 million.
GUIDANCE:
Chemed Corporation sees FY2018 EPS of $10.60-$10.85, versus the consensus of... More
